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The critical roles of sortase A (SrtA) and listeriolysin O (LLO) in Listeria monocytogenes
pathogenicity render these two virulence factors as ideal targets for the development
of anti-virulence agents against L. monocytogenes infection. Additionally, the structures
of SrtA and LLO are highly conserved among the members of sortase enzyme
family and cholesterol dependent toxin family. Here, phloretin, a natural polyphenolic
compound derived from apples and pears that has little anti-L. monocytogenes activity,
was identified to simultaneously inhibit LLO expression and neutralize SrtA catalytic
activity. Phloretin neutralized SrtA activity by causing a conformational change in the
protein’s active pocket, which prevented engagement with its substrate. Treatment
with phloretin simultaneously reduced L. monocytogenes invasion into host cells
and blocked the escape of vacuole-entrapped L. monocytogenes into cytoplasm.
Further, L. monocytogenes-infected mice that received phloretin showed lower mortality,
decreased bacterial burden and reduced pathological injury. Our results demonstrate
that phloretin is a promising anti-infective therapeutic for infections caused by
L. monocytogenes due to its simultaneous targeting of SrtA and LLO, which may result
in fewer side effects than those caused by other antibiotics.
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INTRODUCTION
Listeria monocytogenes, a Gram-positive, opportunistic bacterial species, is a common foodborne
intracellular pathogen and the etiological agent of listeriosis, an infection characterized by
gastroenteritis, septicemia, meningitis and miscarriage in humans and animals (Dussurget et al.,
2004; Posfay-Barbe and Wald, 2009). L. monocytogenes is ubiquitous in the natural environment,
and infection with this bacterium results in high mortality, with a rate of 30% or higher, despite
early intervention with antimicrobial therapy (Posfay-Barbe and Wald, 2009; Walland et al.,
2015). The strong resistance of L. monocytogenes to extreme environments, such as those with
a low pH, a high concentration of salt or a cold temperature, makes it difficult to avoid food
contamination (Martinez-Suarez et al., 2016). L. monocytogenes can penetrate the host intestinal
barrier by invading the intestinal epithelium cells, after which it can multiply within the liver and
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spleen, cross the fetal-placental barrier if present, and penetrate
the blood-brain barrier (Cossart, 2011). These critical processes
are closely associated with virulence factors for L. monocytogenes,
suggesting that targeting these factors could serve as an
alternative therapeutic strategy for bacterial infection (Dussurget
et al., 2004). Unlike traditional antibiotic therapy, targeting
virulence factors, which are not essential for bacterial viability,
will create less selective pressure for developing drug resistance.
This approach would also preserve the host’s endogenous
microbiome and expand the repertoire of bacterial targets
(Clatworthy et al., 2007).
L. monocytogenes gains access to the host intracellular
environment via internalin and other LPXTG-anchored cell-
wall proteins, which promote the bacterium’s entry into
both professional and non-professional phagocytes through
phagocytosis or a zipper-like mechanism (Dussurget et al., 2004;
Carvalho et al., 2014). During this process, L. monocytogenes
becomes entrapped in internalization vacuoles and then escapes
into cytosol, where it can rapidly replicate by secreting a pore-
forming toxin known as listeriolysin O (LLO) (Hamon et al.,
2012). Another surface protein, ActA, hijacks the actin-assembly
machinery of the host cell, which powers the motility of L.
monocytogenes into or between infected cells and neighboring
cells without exposing the bacteria to extracellular space, enabling
it to evade the host immune system (Reddy and Lawrence,
2014). Thus, virulence factors produced in the correct host
environment and at the correct time are indispensable for
successfully establishing a robust infection by L. monocytogenes.
Previous gene knockout studies have shown that disruption of
any of these processes significantly attenuates the virulence of
L. monocytogenes both in vitro and in vivo (Bierne et al., 2002;
Lety et al., 2002; Yin et al., 2011). The anchoring of the LPXTG
motif that is found in the surface proteins of most Gram-positive
bacteria is catalyzed by the transpeptidase sortase A (SrtA)
(Bierne et al., 2002). Thus, this protein is another target for anti-
infective therapy. Furthermore, the virulence-associated proteins
required for these processes are not essential for bacterial growth.
Therefore, interruption of the bacterial lifecycle by targeting the
virulence factors described above would be an alternative strategy
for fighting L. monocytogenes infection without adding selective
pressure.
In agreement with this idea, in previous works, we
significantly decreased the pathogenicity of L. monocytogenes
both in vitro and in vivo by targeting LLO or SrtA using
treatments with natural compounds (Wang et al., 2015a;
Li et al., 2016). We therefore reasoned that a better anti-
infective therapeutic effect may be observed using an inhibitor
that simultaneously targets both LLO and SrtA. Phloretin, a
natural dihydrochalcone flavonoid compound found in apples
and in apple-derived products, has been proven to possess
a potent antioxidant activity in peroxynitrite scavenging and
the inhibition of lipid peroxidation (Rezk et al., 2002). Here,
phloretin was found to simultaneously inhibit LLO production
and neutralize SrtA activity by using hemolysis assay and SrtA
enzyme activity inhibition assay, respectively.
The invasion of L. monocytogenes into host cells and bacterial
escape from internalization vacuoles into cytoplasm were both
blocked by treatment with phloretin. Furthermore, phloretin
treatment dramatically reduced L. monocytogenes virulence in
mice. The results presented in this study indicate that phloretin is
an effective anti-infective agent for L. monocytogenes through its
simultaneous targeting of LLO and SrtA.
MATERIALS AND METHODS
Bacterial Strains, Reagents, and Growth
Conditions
Phloretin was obtained from Sigma-Aldrich (St. Louis, MO,
USA). The L. monocytogenes EGDe wild-type strain BUG
1600, L. monocytogenes EGDe1srtA strain BUG 1777 and
L. monocytogenes EGDe1hly strain BUG 3649 were gifts
from Dr. Pascale Cossart (Institut Pasteur, Paris, France). L.
monocytogenes strains were grown in Trypticase Soy Broth (TSB,
Qingdao Hope Biol-Technology Co., Ltd) supplemented with or
without phloretin at 37◦C.
Hemolysis Assay
Overnight cultures of EGDe were enlarged and cultured into
fresh TSB (1:100) at 37◦C for 2 h with shaking and then
treated with various concentrations of phloretin until the optical
density (OD) at 600 nm reached 2.0, at which point they were
harvested (8000 g, 5min). The bacterial culture supernatants
were incubated with rabbit erythrocytes (final concentration
of 2.5%) in PBS (35mM Na3PO4, 125mM NaCl, 0.5mg/mL
BSA, pH 5.5) at 37◦C for 30min, and then the hemolytic
activity of each sample was determined by measuring the release
of hemoglobin in supernatants at an OD of 543 nm after
centrifugation (8000 g, 1min).
To examine the direct effect of phloretin on hemolysis
induced by bacterial culture supernatants, the hemolytic activities
of bacterial culture supernatants pre-incubated with various
concentrations of phloretin were determined as described above.
Western Blotting Assay
Equal volume of the supernatants described as in hemolysis
assay was separated by SDS-PAGE, and proteins were transferred
onto polyvinylidene fluoride membranes. After blocking in
5% non-fat dry milk, the membranes were incubated with
a primary rabbit anti-LLO antibody (Abcam) diluted 1:2000
and a horseradish peroxidase-conjugated secondary antibody
(Proteintech) diluted 1:3000. Signals were visualized on a Tanon-
4200 imager using Amersham ECL Western blotting detection
reagents (GE Healthcare, Buckinghamshire, UK).
To detect LLO synthesis in L. monocytogenes, the above-
described bacterial pellets were lysed by sonication in PBS
(35mM Na3PO4, 125mM NaCl, 0.5mg/mL BSA, pH 5.5). The
cell lysate was centrifuged at 13,000 rpm for 10min, and the level
of LLO was detected by Western blotting.
Agar Assay and β-Galactosidase Activity
Analysis
The phly-lacZ plasmid was a kind gift from Dr. Birgitte
Kallipolitis (University of Southern Denmark) and was
electroporated into EGDe cells to perform an agar assay as
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described previously (Kastbjerg et al., 2010). A 25-ml aliquot
of TSB agar was melted at 44◦C and supplemented with X-gal
(150µg/ml) and kanamycin (50µg/ml) before being thoroughly
mixed with 1 ml of an overnight culture of bacteria containing
the phly-lacZ plasmid. Nine wells were made per plate following
desiccation in Class II biosafety cabinet at room temperature. A
30-µl aliquot of phloretin or benzalkonium bromide at varying
concentrations was added to each well. The plates were incubated
for 48 h at 37◦C. The β-galactosidase activities of the phly-lacZ-
containing bacteria treated with various concentrations of
phloretin were quantitatively determined as previously described
(Larsen et al., 2006).
Construction, Expression and Purification
of SrtA and Its Mutants
Expression vectors for SrtA mutants (SrtA T90A, SrtA I103A,
and V129A) were constructed using a QuikChange site-directed
mutagenesis kit (Stratagene, La Jolla, CA, USA) based on
the SrtA1N70-pGEX-6P-1 construct, a vector created in
our lab for the expression of wild type SrtA (WT-SrtA) (Li
et al., 2016). The primer pairs for these three mutations were
as follows: T90A forward, 5′-GAATATACAGTTGCGGAAACA
AAAAC-3′; T90A reverse, 5′-GTTTTTGTTTCCGCAACTGTA
TATTC-3′; I103A forward, 5′-GATGAAACAGAAGTAAGC
GTTGCGGATAATACGAAAGATGCTAG-3′; I103A reverse,
5′-CTAGCATCTTTCGTATTATCCGCAACGCTTACTTCT
GTTTCATC-3′; V129A forward, 5′-GAAACGTTTTGTCGC
AGCGGGTGAGCTAGAAAAAAC-3′; and V129A reverse, 5′-
GTTTTTTCTAGCTCACCCGCTGCGACAAAACGTTTC-3′.
The expression and purification of WT-SrtA and its derivatives
was carried out as described in our previous study (Li et al.,
2016).
Sortase A Enzyme Activity Inhibition Assay
WT-SrtA or its derivatives (4mM) were incubated with the
indicated concentrations of phloretin (14.59 or 58.34µM) at
37◦C for 20min in reaction buffer (50mM Tris-HCl, 5mM
CaCl2, and 150mM NaCl, pH 8.0), and then a catalytic
reaction was triggered by adding the fluorescent peptide substrate
Dabcyl-QALPTTGEE (Edans) (GL Biochem, Shanghai, China).
Following another incubation at 37◦C for 1 h, the fluorescence
intensity of each sample was determined at emission and
excitation wavelengths of 350 and 520 nm, respectively, in a black
96-well plate.
Susceptibility Assays
The minimal inhibitory concentration (MIC) of phloretin for
L. monocytogenes EGDe cells (5× 105 CFUs/ml) was determined
in TSB at 37◦C according to the procedure described by Langfield
et al. (2004). The growth of L. monocytogenes EGDe cells cultured
with the indicated concentrations of phloretin was tested by
determining the OD of each sample at 600 nm every 30min.
Molecular Modeling
The starting structure of SrtA for molecular dynamics (MD)
simulations was constructed using a homology modeling method
based on an X-ray crystal structure from the Protein Data
Bank (PDB code 4CDB). The standard docking procedure for
a rigid protein and a flexible ligand in AutoDock 4.0 was used
for molecular docking. Following this, molecular modeling of
SrtA with phloretin was performed using computational biology
methods described in our previous reports (Dong et al., 2013; Niu
et al., 2013).
Determination of Phloretin Binding Affinity
for SrtA
The binding constant (KA) for phloretin with SrtA was
measured using a fluorescence-quenching method. A 280-nm
excitation wavelength with a 5-nm band-pass and a 345-nm
emission wavelength with a 10-nm band-pass were used for
the measurements. The details of the protocol used to perform
the measurements were as previously described (Bandyopadhyay
et al., 2002; Jurasekova et al., 2009).
Cell Culture
The Caco-2 cell line was maintained in RPMI-1640 medium
with 10% fetal bovine serum, non-essential amino acids and
antibiotics in a humidified atmosphere at 37◦Cwith 5%CO2. The
cells were routinely adjusted to a concentration of 3 × 105 cells
per ml, seeded into 24-well plastic culture microplates (3 × 105
per microplate) and cultured for 48 h for immunostaining and
the determination of intracellular bacterial growth. To assay
LDH release, cell monolayers were incubated overnight in culture
medium without antibiotics in 96-well plates (2 × 104 cells per
well).
LDH Release Assay
Caco-2 cells grown in 96-well microplates were infected with L.
monocytogenes pre-exposed or not to phloretin at amultiplicity of
infection (MOI) of 100. Following infections with discriminatory
concentrations of phloretin for 5 h, the LDH released into the
supernatants of the co-culture system was determined using a
Cytotoxicity Detection Kit (LDH; Roche, Basel, Switzerland) as
previously described (Wang et al., 2015a).
Determination of Intracellular Viable
Bacteria
Caco-2 cells were co-cultured with L.monocytogenes at anMOI of
100. Following incubation with or without phloretin (58.34µM)
for 1, 3, or 5 h, intracellular viable bacteria were counted using a
colony-forming unit (CFU) assay after thoroughly lysing the cells
with 1% bioclean Triton-X100 as previously described (Decatur
and Portnoy, 2000). In each case, gentamicin (20µg/ml) was
added 30min after bacterial internalization.
Immunostaining and Confocal Microscopy
Caco-2 cells were inoculated with bacterial suspensions pre-
cultured with or without phloretin (58.34µM) and adjusted to
obtain an MOI of 100. Following incubation with or without
phloretin for 0.5 h, the cells were washed three times with PBS
before treatment with gentamicin (10µg/ml) with or without
phloretin.
For invasion assays, cells were washed three times with PBS
at 1 h post-infection, fixed with 4% paraformaldehyde for 20
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min, blocked with 5% BSA in PBS for 1 h and incubated with a
rabbit L. monocytogenes-specific antibody (Abcam) and an Alexa
Fluor 594-conjugated chicken anti-rabbit antibody (Molecular
Probes) to stain extracellular bacteria. A 0.3% concentration of
Triton X-100 was added to permeabilize the cells for 4min prior
to stain the total bacteria (intracellular + extracellular) with a
rabbit L. monocytogenes-specific antibody (Abcam) and an Alexa
Fluor 488-conjugated chicken anti-rabbit antibody (Molecular
Probes).
To measure bacterial escape from vacuoles into cytoplasm,
cells were washed three times with PBS at the indicated time
points, covered with 4% paraformaldehyde for 20min to fix the
cytoskeleton and adherent or intruded bacteria, permeabilized
with 0.3% Triton X-100 for 4min and blocked with 5% BSA
in PBS for 1 h. F-actin in host cells and bacteria was stained
with Alexa Fluor 488-conjugated antibodies against phalloidin
(green) and a rabbit L. monocytogenes-specific antibody (Abcam)
conjugated to Alexa Fluor 594 (red), respectively; nuclei were
stained in blue with DAPI.
Mouse Infections
Female 6- to 8-week-old BALB/c mice were purchased from Liao
Ning Chang Sheng Biotechnology Co., LTD. The mice used for
the experiments were housed and handled in accordance with
the guidelines established by the United States National Institutes
of Health. These studies were reviewed and approved by the
Institutional Animal Care and Use Committee of Jilin University.
Overnight cultures of L. monocytogenes were enlarged by
culturing into fresh TSB (1:100) at 37◦C with shaking until
the OD at 600 nm reached 1.0, at which point they were
harvested. The cell pellets were washed and suspended in normal
saline. To establish an infection model, 200µL prepared bacterial
suspension (1 × 108 CFU/ml) was intraperitoneally inoculated
into BALB/c mice. The infected mice in the treatment group were
subcutaneously administered 150 mg/kg of phloretin 2 h after
infection and again at 8-h intervals. The infected mice in the
positive group were injected with an equal volume of dimethyl
sulfoxide (DMSO) at the same time points. Finally, a group of
healthy mice received only phloretin to examine the toxicity of
the drug. Each group had 10 mice, and the therapeutic trial
lasted for 96 h; survival statistics were collected throughout this
period.
For histopathologic analysis, the mice were euthanized with
anesthesia following cervical dislocation at 48 h post-infection.
Liver and spleen tissues were removed, fixed with formalin,
embedded in paraffin, stained with hematoxylin and eosin and
visualized by light microscopy. To analyze the bacterial burden
in tissue, the liver and spleen tissues collected from the sacrificed
mice were weighed, lysed in 2%Triton X-100 and inoculated onto
TSB agar plates at 37◦C overnight.
Statistical Analysis
All experimental data were expressed as the mean ± SEM
(n≥ 3). GraphPad Prism 5.0 was used for statistical analysis using
Student’s t-test. Significance levels of p < 0.05 and p < 0.01 are
indicated in the figures.
RESULTS
Phloretin Simultaneously Inhibits LLO
Expression and Neutralizes SrtA Activity in
L. monocytogenes
Potential inhibitors of L. monocytogenes virulence factors were
identified using a phenotypic assay based on protein function
(Wang et al., 2015a,b; Li et al., 2016). In this work, the hemolytic
activities of culture supernatants of L. monocytogenes EGDe
cells dose-dependently decreased after co-culture with various
concentrations of phloretin (7.3–58.34µM) (Figures 1A,B).
However, pre-incubation with phloretin did not affect the
hemolytic activities of bacterial culture supernatants (Figure 1B),
suggesting that this compound effectively inhibits LLO maybe by
preventing its expression. To further validate these observations,
western blotting was employed, and the results were consistent
with those from the hemolytic activity assay: the LLO levels
in bacterial culture supernatants and cell pellets co-cultured
with phloretin were reduced in a concentration-dependent
manner (Figure 1C). These data implied that the observed LLO
inhibition was due to a phloretin-induced decrease of LLO
synthesis at the transcriptional or translational level. However,
phloretin treatment did not affect the transcription of hly, the
gene encoding LLO, according to an agar assay (Figure 1D)
and β-galactosidase activity analysis (Figure 1E) using a phly-
lacZ-containing bacterial construct. Furthermore, phloretin also
effectively inhibited the catalytic activity of SrtA based on a
SrtA activity inhibition assay that used the fluorescent peptide
substrate Dabcyl-QALPTTGEE-Edans. The IC50 for phloretin-
induced inhibition was 37.24µM under our experimental
conditions (Figure 2A). Importantly, phloretin showed little
anti-microbial activity against L. monocytogenes, with a MIC
of 933.44 µM, which is 16-fold higher than the concentration
used for the SrtA activity inhibition assay and hemolytic
activity analysis. Additionally, the growth of L. monocytogenes
was not apparently affected following treatment with phloretin
at the concentrations required for sufficient inhibition of
LLO expression and SrtA catalytic activity (Figure 2B). Taken
together, our results established that phloretin, a natural
polyphenolic compound widely found in apple and pears with
little anti-L. monocytogenes activity, was an effective inhibitor
that simultaneously neutralized SrtA activity and inhibited LLO
expression in L. monocytogenes. These results indicate that
phloretin may represent an effective anti-infective candidate for
L. monocytogenes infection without putting selective pressure on
this bacterium.
Molecular Dynamics Simulations of the
SrtA-Phloretin Interaction
To further characterize the mechanism underlying phloretin-
induced inhibition of SrtA activity, the preferential binding
mode of SrtA with phloretin was determined based on 100-ns
MD simulations. The details of the interaction formed between
SrtA and phloretin were obtained using molecular modeling.
To indicate the convergence of a complex structure, the RMSD
values for SrtA in the whole system as a function of time are
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FIGURE 1 | Phloretin inhibits LLO expression in L. monocytogenes. (A) The chemical structure of phloretin. (B) The effect of phloretin on the hemolytic activities
of bacterial culture supernatants. Inhibition of hemolytic activity in culture supernatants of L. monocytogenes after co-culture with phloretin. L. monocytogenes was
co-cultured with various concentrations of phloretin until reaching a stationary phase, and the hemolytic activities of the culture supernatants from each sample were
determined using hemolysis assays. However, no inhibition of hemolytic activity for bacterial culture supernatants was observed following a direct pre-incubation with
various concentrations of phloretin. (C) Western blotting analysis to detect LLO levels in culture supernatants and cell pellets. L. monocytogenes was co-cultured with
various concentrations of phloretin until reaching a stationary phase, and the LLO level in the culture supernatants and cell pellets were determined by
immunoblotting. Lanes 1–5, samples treated with 0, 7.30, 14.59, 29.17, and 58.34 µM phloretin. (D,E) No inhibition of hly transcription was produced by phloretin.
Bacteria containing phly-lacZ plasmids were incubated with various concentrations of phloretin in TSB agar (D) or TSB (E). (D) Phloretin was added at increasing
concentrations in wells 1–6 (0–116.68 µM); well 8 contained a 40% benzalkonium bromide solution; and well 9 contained a 60% benzalkonium bromide solution. (E)
β-galactosidase activity was evaluated using a β-galactosidase staining kit and the values were obtained by comparing with data of phloretin-free samples (taken
as 100%). *P < 0.05; **P < 0.01.
shown in Figure 3B. The backbone RMSD of SrtA reached
equilibrium after ∼20 ns of simulation, validating that the final
60 ns of the simulation were suitable for analysis. As shown
in Figure 3A, the potential binding mode of phloretin with
the active site of SrtA was determined based on 100-ns MD
simulations. The results revealed that phloretin can bind to SrtA
via intermolecular forces. In this complex system, phloretin could
localize to the specific binding pocket of SrtA, adjacent to the
active region of SrtA. Furthermore, the side chains of phloretin
can form strong interaction with Thr90, Glu91, Ile103, Asp104,
Asn105, and Val129 in SrtA (Figure 3A).
To identify the binding sites used by the SrtA-phloretin
complex system, the MM-PBSA method was used to calculate
the binding free energy between the residues surrounding the
binding site and phloretin. As shown in Figure 3C, Ile103,
Asp104, Asn105, and Val129 have the strongest total binding
energy contribution, with an 1Etotal of ≤ −1.4 kcal/mol. In
addition, residues Thr90, Glu91, and Arg110 also have an
appreciable total binding energy contribution, with an 1Etotal
of ≤ −1.0 kcal/mol (Figure 3C). These results suggest that these
five residues are key residues for the binding of phloretin
to SrtA.
The total binding free energy for the SrtA-phloretin complex
and the detailed energy contributions were calculated according
to theMM-PBSA approach, as summarized inTable 1. According
to the calculation results, the binding free energy, 1Gbind, of
the interaction between phloretin and SrtA decreased in the
following order: WT-SrtA > mutants, meaning that WT-SrtA
has the strongest ability to bind with phloretin. By fluorescence-
quenching spectroscopy, we measured the 1Gbind and the
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FIGURE 2 | Phloretin inhibits SrtA catalytic activity in L. monocytogenes. (A) Inhibition of SrtA catalytic activity by phloretin. Purified SrtA was pre-incubated
with phloretin at 37◦C for 30min and then mixed with the fluorescent peptide substrate Dabcyl-QALPTTGEE-Edans. Following incubation at 37◦C for 1 h, the
fluorescence values of the reaction system were determined using emission and excitation wavelengths of 350 and 520 nm, respectively. (B) Growth curve of
L. monocytogenes in the presence of various concentrations of phloretin. (C) The effects of phloretin on the catalytic activities of WT-SrtA and SrtA mutants.
number of binding sites between phloretin and the two mutants;
these results were highly consistent with those obtained by
computational methods (Table 1). Furthermore, the inhibitory
effect of phloretin against SrtA mutant activity (SrtA T90A,
SrtA I103A, and V129A) is much lower than that against WT-
SrtA (Figure 2C). These results indicate that the information
generated by the MD simulations of the SrtA-phloretin complex
is reliable. Thus, upon the binding of phloretin with the active
region of SrtA (residues Thr90, Glu91, Ile103, Asp104, Asn105,
Arg110, and Val129), the biological activity of SrtA was inhibited.
Phloretin Simultaneously Inhibits
L. monocytogenes Invasion and Escape
from Internalization Vacuoles in Caco-2
Cells
Cell-surface proteins containing the peptide motif LPXTG
are linked to cell walls by SrtA and facilitate L. monocytogenes
invasion into host cells (Li et al., 2016). Following internalization,
secreted LLO facilitates L. monocytogenes escape from
internalization vacuoles into cytoplasm by lysing biomembranes
(Hamon et al., 2012). The in vitro inhibition of SrtA catalytic
activity and LLO expression by phloretin led us to analyze the
effects of phloretin treatment on L. monocytogenes invasion
into host cells and escape from vacuoles. A CFU assay was
employed to measure the total number of bacteria adhered to
and invaded into host cells at 1 h post-infection. In line with our
earlier research, phloretin pre-treated EGDe bacteria showed a
significantly diminished ability to invade cells, but this inhibition
was not observed for cells that did not receive the pre-treatment
(Figure 4A). Additionally, no difference was observed for the
samples infected with EGDe1srtA co-treated or pre-treated with
phloretin, suggesting that the inhibition of phloretin against
bacterial entry by targeting SrtA. Immunostaining was used
to locate extracellular or endocellular bacteria. Extracellular L.
monocytogenes were stained in red, while total L. monocytogenes
(intracellular + extracellular) were stained in green. Consistent
with our previous study, the L. monocytogenes EGDe strain
could effectively internalize into Caco-2 cells when co-cultured
with host cells; however, the internalization was significantly
defective for strain EGDe1srtA. Pre-treatment with phloretin
significantly reduced the entry of EGDe bacteria into host cells
(Figure 4B). To directly observe the details of this inhibition,
F-actin in host cells and bacteria were stained with Alexa Fluor
488-conjugated phalloidin antibodies (green) and Alexa594-
conjugated antibodies (red), respectively. DAPI was used for
nuclear staining. In line with the above results, bacterial entry
into host cells was reduced only for the samples infected with
EGDe cells pre-exposed to phloretin (Figure 5). At 3 h or 5 h
post-infection, in contrast to the findings for the EGDe1hly
bacteria, most of the EGDe bacteria colocalized with F-actin,
indicative of their cytosolic localization (Figure 5). Although the
entry of EGDe1SrtA bacteria was substantially reduced, their
escape from vacuoles into cytoplasm appeared similar to the
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FIGURE 3 | The 3D structure of SrtA in complex with phloretin determined by molecular modeling. (A) The 3D structure of the SrtA-phloretin complex. (B)
The RMSD values of the backbone atoms of SrtA during MD simulations of the binding of SrtA to phloretin. (C) Decomposition of binding energy on a per-residue
basis for the residues in the binding site of SrtA as the SrtA-phloretin complex formed. (D,E) Distances between Ala53-Ile114 and His55-Arg125 as a function of time.
The black line (Ala53-Ile114 in the protein complex), red line (His55-Arg125 in the protein complex), green line (Ala53-Ile114 in free protein) and blue line
(His55-Arg125 in free protein) represent the distances between the same residues.
EGDe bacteria. Importantly, bacterial escape was significantly
decreased in the cells infected with the EGDe strain, regardless
of whether pre-incubation with phloretin occurred (Figure 5).
Taken as a whole, our data indicate that pre-treatment of EGDe
cells with phloretin simultaneously inhibits L. monocytogenes
invasion into Caco-2 cells and cell escape from internalization
vacuoles.
Phloretin Reduces Cytosolic
L. monocytogenes Multiplication and
Bacteria-Induced Cytotoxicity
The numbers of viable bacteria present in the cytoplasms of an
infected cell monolayer with or without phloretin treatment were
determined with CFU assays at 1, 3, and 5 h after infection.
The wild type EGDe strain showed uninhibited growth in
cytoplasm, while the endocellular growth of the EGDe1hly
strain was obviously suppressed (Figure 6A). Importantly, the
addition of phloretin during infection significantly reduced
the multiplication of intracellular bacteria (Figure 6A). The
release of LDH into culture supernatant is an indicator of
cell death. All the phloretin-treated groups showed decreased
LDH release compared with the control group that was infected
with EGDe cells but not treated with phloretin (Figure 6B),
indicating that cell death was reduced in the presence of
phloretin. This inhibitory effect was much more pronounced
in the sample infected with bacteria pre-treated with phloretin
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 January 2017 | Volume 7 | Article 9
Wang et al. Inhibition of L. monocytogenes Infection
TABLE 1 | The binding free energies (kcal/mol) of the WT-LIG, T90A-LIG,
I103A-LIG, and V129A-LIG systems based on computational methods, and
the values of the binding constants (KA) based on
fluorescence-quenching spectroscopy.
WT-SrtA T90A I103A-LIG V129A
Computational
method
−13.8 ± 1.9 −9.7 ± 1.4 −8.6 ± 1.7 −8.5 ± 1.2
KA (1 × 10
4)
L·mol−1
7.93 ± 1.32 5.71 ± 1.44 5.80 ± 1.33 4.98 ± 1.37
compared to the sample infected with bacteria without the
pre-treatment (Figure 6B). Furthermore, pre-treatment with
14.59µMphloretin provided greater protection against cell death
mediated by the EGDe strain compared to treatment with
58.34µM phloretin during infection (Figure 6B). Additionally,
phloretin treatment did not significantly induce cytotoxicity in
Caco-2 cells. Taken together, our results show that phloretin
reduces cytosolic L. monocytogenes multiplication and bacteria-
induced cytotoxicity by simultaneously targeting LLO and
SrtA.
Phloretin Protects Mice from
L. monocytogenes Infection
Mutants lacking SrtA or LLO exhibited remarkably decreased
virulence, as shown in our previous work, in a mouse model
of L. monocytogenes infection (Wang et al., 2015a; Li et al.,
2016). Here, the observed phloretin-mediated inhibition against
L. monocytogenes invasion into host cells and escape from
internalization vacuoles into cytoplasm prompted us to further
evaluate the therapeutic effects of this compound for L.
monocytogenes infection in a mouse model. Consistent with
previous studies, 75% of infected mice had died within 96 h
after intraperitoneal injection of 2 × 107 CFUs of bacteria
per mouse, with a median survival time of 78 h (Figure 7A).
However, only 25% of the infected mice that were treated
with phloretin had died by 96 h post-infection (Figure 7A).
The infected mice that had received phloretin exhibited a
significantly higher survival rate than the control group treated
with DMSO (Figure 7A). Furthermore, the mice treated only
with phloretin and not subjected to bacterial infection all
survived, indicating that phloretin itself has no toxicity to
mice (Figure 7A). CFUs on TSB agar plates were counted
to measure the bacterial burden present in liver or spleen
tissues isolated from infected mice treated with or without
phloretin. As expected, the numbers of viable bacteria colonized
in the livers and spleens of the phloretin-treated mice were
significantly lower than those from the infected mice treated
with DMSO (Figure 7B). Gross inspection indicated that the
liver tissues of the infected mice treated with DMSO became
gray in appearance with white necrotic foci, while the spleen
tissue from this group became dusky-red in color and had a
tight texture (Figure 7C). In contrast, the pathological changes
in the infected mice that received phloretin were clearly
ameliorated (Figure 7C). Furthermore, no pathological changes
were observed in the uninfected mice treated with phloretin,
FIGURE 4 | Phloretin reduces L. monocytogenes invasion into Caco-2
cells. (A) Caco-2 cells were infected with phloretin (58.34µM) pre-treated
L. monocytogenes or L. monocytogenes with or without phloretin treatment
(58.34µM) during infection for 1 h, and the total number of viable bacteria in
cells was counted after lysing the cells. (B) L. monocytogenes pre-cultured
with or without phloretin (58.34µM) were co-incubated with host cells at an
MOI of 100 in the presence or absence of phloretin (58.34µM). At 1 h
post-infection, extracellular and total bacteria were stained with
Alexa594-conjugated antibodies (red) and Alexa488-conjugated antibodies
(green), respectively. Consistent with the samples infected with the EGDe1srtA
strain, only the cells infected with phloretin-pre-treated L. monocytogenes
showed reduced bacterial entry. Scale bar, 10µm. *P < 0.05; **P < 0.01.
further suggesting that phloretin has no toxicity for mice
(Figure 7C). In agreement with these findings, evaluation of
tissue sections showed significant accumulations of inflammatory
cells (dark blue or purple) in the infected mice treated with
DMSO (Figure 7D). However, only minor inflammatory lesions
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FIGURE 5 | Phloretin simultaneously inhibits L. monocytogenes invasion into host cells and escape from internalization vacuoles. L. monocytogenes
pre-cultured with or without phloretin (58.34µM) were co-incubated with host cells at an MOI of 100 in the presence or absence of phloretin (58.34µM). At 1, 3, and
5 h post-infection, F-actin in the host cells and bacteria was stained with Alexa Fluor 488-conjugated phalloidin antibodies (green) and Alexa Fluor 594-conjugated
antibodies (red), respectively; nuclei were stained blue with DAPI. Infection with EGDe cells showed invasion of bacteria into host cells and bacterial escape from
vacuoles, as indicated by the numerous bacteria (red) observed in the cells at 1 h post-infection and the fact that most bacteria (red) were surrounded by actin (green)
at 5 h post-infection. Significant defects in host cell invasion and bacterial escape from vacuoles were observed for the samples infected with EGDe1srtA or
EGDe1hly cells. Note that phloretin treatment remarkably inhibited the escape of EGDe cells from vacuoles into cytoplasm, indicated by the fact that the majority of
bacteria were not surrounded by F-actin. Importantly, significantly reduced bacterial invasion was observed for the samples infected with EGDe cells pre-treated with
phloretin, but not samples infected with EGDe cells without phloretin pre-treatment. Scale bar, 10µm.
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FIGURE 6 | Inhibition of cytosolic L. monocytogenes multiplication and
bacteria-induced cytotoxicity by phloretin. (A) Caco-2 cells were infected
with L. monocytogenes in the presence or absence of phloretin (58.34µM).
After 1, 3, and 5 h of infection, cells were lysed with 0.2% Triton X-100, and
CFUs were counted on coverslips to determine the intracellular growth rates of
the bacteria. (B) Cells were infected with phloretin-pre-treated
L. monocytogenes at the indicated concentrations or non-pre-treated
L. monocytogenes for 5 h, and LDH release was detected using a Cytotoxicity
Detection Kit to evaluate the cytotoxicity induced by L. monocytogenes. *P <
0.05; **P < 0.01.
were found in the phloretin-treated mice infected with L.
monocytogenes, and no gross lesions or pathological changes
were observed in the uninfected mice that received phloretin
(Figures 7C,D). Taken together, our results show that phloretin
treatment provides systemic protection against L. monocytogenes
infection in mice.
DISCUSSION
Many surface proteins in most Gram-positive bacteria are
covalently linked to the cell wall by the transpeptidase SrtA
(Spirig et al., 2011). These proteins are crucial for the adherence,
invasion and colonization of bacteria during infection, especially
for the intracellular bacteria L. monocytogenes (Mariscotti et al.,
2012; Li et al., 2016). Following internalization into host cells,
the pore-forming toxin LLO, one of the members of the
cholesterol-dependent cytolysin (CDC) family, breaches the
phagosomal membranes of host cells, facilitating the escape
of L. monocytogenes entrapped in internalization vacuoles into
cytoplasm without host immune recognition (Hamon et al.,
2012). Knockout of SrtA or LLO from L. monocytogenes
significantly affects bacterial internalization (Bierne et al.,
2002) and vacuole escape (Hamon et al., 2012), respectively.
Furthermore, the virulence of these mutant strains was
remarkably decreased in a mouse model (Bierne et al., 2002; Lety
et al., 2002), indicating that both SrtA and LLO are potential
anti-virulence drug targets for combatting L. monocytogenes
infection. In our previous studies, treatment with chalcone (Li
et al., 2016), an inhibitor of SrtA, or fisetin (Wang et al.,
2015a), an inhibitor of LLO, provided robust protection against
L. monocytogenes infection in vitro and in vivo. However, the
therapeutic effects of chalcone and fisetin for L. monocytogenes
infection are unsatisfactory due to only one virulence factor
targeted by the natural compounds. Thus, we reasoned that an
agent that could simultaneously target both virulence factors
would produce better results.
To validate this hypothesis, phloretin, a natural polyphenolic
compound derived from apples and pears (Crespy et al.,
2001) with little anti-L. monocytogenes activity, was identified
as an effective inhibitor of L. monocytogenes that could
simultaneously target SrtA and LLO according to a SrtA catalytic
activity inhibition assay and a hemolysis assay. SrtA catalytic
activity and LLO expression in bacterial culture supernatant
and cell lysate were both significantly inhibited following
treatment with 58.34 µM phloretin. However, the phloretin
treatment did not affect the transcription of hly, indicating
that the decreased LLO expression may have resulted from
inhibition of LLO translation in cytoplasm. Additionally, the
half maximal inhibitory concentration (IC50) of phloretin
against SrtA was measured as 37.24 µM. Furthermore, the
growth of L. monocytogenes was not visibly affected by the
presence of phloretin at the concentration required for such
inhibition. These data indicate that phloretin may represent
an effective anti-virulence agent that works by simultaneously
targeting SrtA and LLO without putting selective pressure on
L. monocytogenes. Consistent with this idea, the invasion of L.
monocytogenes into Caco-2 cells was significantly blocked after
an overnight incubation with phloretin, however, this inhibition
was not observed for the samples without phloretin treatment.
Furthermore, treatment with phloretin attenuated the escape of
L. monocytogenes into cytoplasm, leading to degradation of the
bacteria by host cells. Although the cytotoxicity induced by L.
monocytogenes was attenuated in the presence of either a SrtA
inhibitor or an LLO inhibitor, pre-incubation of bacteria with
phloretin overnight provided more effective protection against
L. monocytogenes-mediated cytotoxicity than no pre-incubation.
This difference was also observed between samples pre-incubated
with a lower concentration of phloretin (14.59µM) and those co-
incubated with a higher concentration of phloretin (58.34µM).
Therefore, phloretin inhibited L. monocytogenes invasion and
escape from vacuoles by simultaneously targeting SrtA and
LLO. More importantly, phloretin treatment provided robust
protection against L. monocytogenes infection in a mouse model.
To the best of our knowledge, this is the first study to
demonstrate that an inhibitor that simultaneously targets these
two virulence factors can be an effective anti-infective against L.
monocytogenes.
To further characterize the mechanism by which phloretin
inhibits SrtA activity, a MD simulation of SrtA-phloretin binding
was performed. The binding of phloretin to a specific binding
pocket on SrtA critically affected the binding of SrtA to
its substrate. We thus analyzed the potential conformational
changes in SrtA upon binding to phloretin using aMD-simulated
trajectory. In the free protein, the distances between Ala53-Ile114
and His55-Arg125 (in the active pocket of SrtA) ranged from
0.42 to 0.58 nm and 0.79 to 1.02 nm over the time course
of the simulation, with average distances of 0.54 and 0.88 nm
(Figures 3D,E). Notably, in the SrtA-phloretin complex, these
distances ranged from 0.45 to 0.64 nm and 0.92 to 1.44 nm,
with average distances of 0.59 and 1.19 nm (Figures 3D,E). The
changes in the distances between Ala53-Ile114 andHis55-Arg125
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FIGURE 7 | Phloretin protects mice from L. monocytogenes infection. Mice were intraperitoneally infected with L. monocytogenes and treated with phloretin or
DMSO as a control. The mice were sacrificed 48 h post-infection to determine the bacterial burden and analyze the pathological damage resulting from infection. (A)
Survival analysis of infected or uninfected mice treated with phloretin over a 96-h period. (B) Bacterial burdens in the livers and spleens of the infected mice. Treatment
with phloretin alleviated the gross pathological changes (C) and histopathological changes (D) observed in the livers and spleens of the infected mice. Scale bar,
50µm. *P < 0.05; **P < 0.01.
upon SrtA’s interaction with phloretin suggest that the active
pocket of SrtA undergoes a significant conformational change
upon engagement with phloretin (Figures 3D,E). As a result,
the active pocket can no longer interact with the normal
substrate of SrtA, thereby reducing the biological activity of
SrtA.
Both SrtA and LLO are indispensable virulence determinants
for L. monocytogenes virulence. Thus, the double inhibition
of SrtA and LLO caused by phloretin may offer a
more effective anti-virulence strategy for infections with
L. monocytogenes.
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